At the risk of being accused of trying to spin straw into gold, I can't
bring myself to get all that worked up about St. Jude Medical's (STJ)
modest shortfall in Q2 and lower guidance for 2012. Yes, in the
momentum-driven "what have you done for me lately" world of Wall Street,
that's a bad thing. But my bullish thesis on St. Jude wasn't really
about what the company would do in 2012, and the company's long-term
opportunities still look attractive.
Please click here for the full article:
St. Jude Medical's Weaker Guidance Presents Another Opportunity
No comments:
Post a Comment